CRDLCardiol Therapeutics Inc.vs its industry peers
A metric-by-metric comparison of Cardiol Therapeutics Inc. against Biological Products, (No Diagnostic Substances) — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRDL본 종목 | $102M#5 | — | — | — | — | — | — | — | — | — | -3.8%#2 | — |
| BNTX | $22.8B#1 | — | — | — | — | — | — | — | — | — | -13.5%#3 | — |
| CGEN | $193M#4 | 5.4x#2 | 1.9x#1 | 2.7x#1 | 161.1%#1 | 348.4%#1 | 43.1%#1 | 34.4%#2 | — | — | — | — |
| CKDXF | — | — | — | — | -80.0%#7 | 26.1%#3 | -623048.0%#8 | — | — | — | — | — |
| CLDWW | — | — | — | — | — | 10.1%#6 | -44977.8%#7 | -635.4%#7 | — | — | — | — |
| CLLS | — | — | — | — | 75.8%#2 | -83.9%#10 | -45.3%#2 | -89.1%#3 | — | — | -67.4%#6 | — |
| CPMV | — | — | — | — | — | 25.4%#5 | — | — | — | — | — | — |
| CYVNY | — | — | — | — | -80.0%#7 | 26.1%#3 | -623048.0%#8 | — | — | — | — | — |
| DBVT | $3.1B#2 | — | 21.1x#2 | 555.3x#2 | 35.8%#3 | -29.0%#8 | -2609.2%#4 | -98.9%#4 | — | — | -30.4%#5 | — |
| DBVTF | — | — | — | — | 35.8%#3 | -29.0%#8 | -2609.2%#4 | -98.9%#4 | — | — | — | — |
| ELUT | — | 0.8x#1 | — | — | -15.0%#5 | 198.9%#2 | -218.9%#3 | 339.0%#1 | -122.6%#1 | — | -16.6%#4 | — |
| ENTX | $542M#3 | 8.9x#3 | 74.6x#3 | 12903.2x#3 | -76.8%#6 | -19.9%#7 | -27450.0%#6 | -157.4%#6 | — | — | 10.6%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-05.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice